Last reviewed · How we verify
NCT05400629
Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1
NA trial testing Training program in Myotonic Dystrophy 1 in 12 participants. Completed in 10 January 2023.
30 June 2022
Quick facts
| Lead sponsor | Université de Sherbrooke |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 12 |
| Start date | 1 January 2022 |
| Primary completion | 30 June 2022 |
| Estimated completion | 10 January 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Training program
Conditions studied
- Myotonic Dystrophy 1 — all drugs for Myotonic Dystrophy 1 →
Sponsor
Université de Sherbrooke — full company profile →
Who can join
Adults 30 to 65, female only, with Myotonic Dystrophy 1. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1.
Davey EE, Légaré C, Planco L, Shaughnessy S, et al · · 2023 · cited 13× · PMID 37318869 · DOI 10.1172/jci.insight.163856 -
Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1.
Di Leo V, Lawless C, Roussel MP, Gomes TB, et al · · 2023 · cited 11× · PMID 37638448 · DOI 10.3233/jnd-230099 -
A 12-Week Strength Training Improves Mitochondrial Respiration, H<sub>2</sub>O<sub>2</sub> Emission and Skeletal Muscle Integrity in Women With Myotonic Dystrophy Type 1.
Marcangeli V, Girard-Côté L, Di Leo V, Roussel MP, et al · · 2025 · cited 1× · PMID 41241935 · DOI 10.1111/apha.70135 -
Effect of exercise training on clinical and physiological variables in adults with myotonic dystrophy type 1: a systematic review and meta-analysis.
Shetty S, Luo Y, Thomas A, Gamil K, et al · · 2026 · PMID 41963558 · DOI 10.1007/s00415-026-13808-y
Verify or expand the search:
- PubMed search for NCT05400629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Training program
Trials testing the same drug.
- NCT07491666 — Effects of Neuromuscular Exercises on Motor Skills in Girls · NA · active not recruiting
- NCT07334054 — Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners · NA · not yet recruiting
- NCT05955300 — Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis · NA · unknown
- NCT04702217 — Physical Activity as a Complementary Treatment in POTS · NA · withdrawn
- NCT05300880 — Health Coaching With Hospitalised Chronic Heart Failure Patients · completed
Other recruiting trials for Myotonic Dystrophy 1
Currently open trials in the same condition.
- NCT07385443 — The Spanish National Registry for Myotonic Dystrophy Type 1 · recruiting
- NCT06378216 — Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe] · recruiting
- NCT03981575 — Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) · recruiting
Other Université de Sherbrooke trials
Trials by the same sponsor.
- NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
- NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
- NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
- NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
- NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05400629 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
- Last refreshed: 10 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05400629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing